David Horváth

Defining the conditions for the development of the emerging class of Fe^III-based MRI contrast agents

Zsolt Baranyai, Fabio Carniato, Alessandro Nucera et al. · Chemical Science · 2021 · 68 citations · Full text

Natural Sciences, Chemistry, Radiology +15

Towards ²¹³Bi alpha-therapeutics and beyond: unravelling the foundations of efficient Bi^III complexation by DOTP

David Horváth, Fabio Travagin, N. Guidolin et al. · Inorganic Chemistry Frontiers · 2021 · 19 citations

Medicine, Medicinal Chemistry, Molecular Pharmaceutics +14

Enhanced relaxivity of Gd^III-complexes with HP-DO3A-like ligands upon the activation of the intramolecular catalysis of the prototropic exchange

Luciano Lattuada, David Horváth, Sonia Colombo Serra et al. · Inorganic Chemistry Frontiers · 2021 · 15 citations

Natural Sciences, Biochemistry, Chemistry +6

Synthesis of Symmetrical Tetrameric Conjugates of the Radiolanthanide Chelator DOTPI for Application in Endoradiotherapy by Means of Click Chemistry

Alexander Wurzer, Adrienn Vágner, David Horváth et al. · Frontiers in Chemistry · 2018 · 13 citations · Full text

Medicine, Chemistry, Pharmacology +17

Boosting Bismuth(III) Complexation for Targeted α‐Therapy (TAT) Applications with the Mesocyclic Chelating Agent AAZTA**

David Horváth, Adrienn Vágner, Dezső Szikra et al. · Angewandte Chemie International Edition · 2022 · 10 citations · Full text

Medicine, Chemistry, Medicinal Chemistry +17